Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

1.010 -0.020 (-1.99%)
Streaming Delayed Price Updated: 9:47 AM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,626
Open 1.030
Bid (Size) 1.000 (12)
Ask (Size) 1.010 (3)
Prev. Close 1.030
Today's Range 1.010 - 1.030
52wk Range 0.7715 - 800.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Study Identifies Key Enzyme That Could Be Targeted to Fight Brain Cancers
Via Investor Brand Network

Performance

YTD
-82.7%
-82.7%
1 Month
-25.8%
-25.8%
3 Month
-80.5%
-80.5%
6 Month
-85.3%
-85.3%
1 Year
-99.8%
-99.8%

More News

Read More
The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035
Via Investor Brand Network
Top stock movements in today's session.
Via Chartmill
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
Via ACCESS Newswire
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
Via ACCESS Newswire
The market is filled with gapping stocks in Tuesday's session.
Via Chartmill
Study Uncovers Drivers of Brain Tumor Growth, Could Open New Treatment Approaches
Via Investor Brand Network
Pitt Researchers Develop Diagnostic Tool for Profiling Pediatric Brain Cancers
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position
Via Investor Brand Network
Firefighters Have an Increased Chance of Having Gene Mutations Associated with Brain Cancer, Study Says
Via Investor Brand Network
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Nasdaq Gains 50 Points; US New Home Sales Rise In February
Via Benzinga
CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Phase 2 Results for Berubicin in Glioblastoma Trial
Via Investor Brand Network
Which stocks are moving before the opening bell on Tuesday?
Via Chartmill
US Stocks Mixed; Core & Main Posts Downbeat Earnings
Via Benzinga
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
Via ACCESS Newswire
Wednesday's session: gap up and gap down stocks
Via Chartmill
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Study Finds Experimental Drug Prolongs the Survival of Glioblastoma Patients
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Updates Cash Position, Nasdaq Compliance, and Clinical Progress
Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 1.010
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 04/30/25 09:47 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.